Type III hyperlipoproteinemia: Diagnosis, molecular defects, pathology, and treatment

Annals of Internal Medicine

Volumn 98, Issue 5, 1983, Pages 623-640

  Brewer Jr , H B ^a   Zech, L A ^a   Gregg, R E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BEZAFIBRATE; CLOFIBRATE; ESTROGEN; GEMCADIOL; METFORMIN; NICOTINIC ACID; OXANDROLONE; PROBUCOL; THYROXINE; APOLIPOPROTEIN; LIPID; LIPOPROTEIN;

ADVERSE DRUG REACTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DIAGNOSIS; DIET; DIGESTIVE SYSTEM; DRUG THERAPY; ETIOLOGY; FLUSHING; GALLSTONE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPOPROTEINEMIA; LIVER; LIVER DISEASE; ORAL DRUG ADMINISTRATION; REVIEW; THERAPY; THROMBOEMBOLISM; ADOLESCENT; ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CORONARY BLOOD VESSEL; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; INTESTINE; MALE; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY; PHENOTYPE; XANTHOMATOSIS;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS; CLOFIBRATE; CORONARY VESSELS; DIET; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE III; INTESTINES; LIPIDS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGE; MOLECULAR WEIGHT; PHENOTYPE; XANTHOMATOSIS;

EID: 0020625776     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-98-5-623     Document Type: Article

References (0)